Why Particle Size Matters: 100-120nm vs Conventional Delivery

Everyone says nano. But size decides result. 100nm difference changes everything.

Conventional products are 3500-5000nm, broad, uneven, 15-25% encapsulation, low stability, burst release, surface effect.

SRIDA is 100-120nm, narrow uniform, 90-95% encapsulation, high stability, sustained release, deep effect.

Less product, more result.

Technology Principles Validated In Peer-Reviewed Research:

Research Area 1: Bioavailability and Delivery
Journals: Pharmacognosy Magazine (2017) • Phytomedicine (2021)
Research focus: Enhanced oral absorption and targeted delivery mechanisms

Research Area 2: Encapsulation Efficiency
Journal: Pharmaceutics (September 2019)
Research focus: Nanoparticle formulation optimizing loading capacity and reproducibility

Research Area 3: Particle Stability and Cellular Uptake
Journal: Pharmaceutics (May 2020)
Research focus: Aggregation resistance and receptor-mediated cellular internalization

Research Area 4: Bioavailability and Release Profile
Journal: Bioorganic Chemistry (2020)
Research focus: Sustained release kinetics and prolonged systemic exposure

Note: Journal names and years refer to research areas validating nano-principles. All journals are PubMed/Scopus indexed.